Assessment of the clinical features of rheumatoid arthritis-related interstitial lung diseases: a retrospective evaluation

被引:1
|
作者
Genc, A. C. [1 ]
Ozturk, Z. [2 ]
Kara, A. B. [3 ]
Genc, F. Turkoglu [1 ]
Aydemir, Y. [4 ]
Gunduz, Y. [3 ]
Gonullu, E. [2 ]
机构
[1] Sakarya Univ, Dept Internal Med, Fac Med, Sakarya, Turkiye
[2] Sakarya Univ, Dept Rheumatol, Fac Med, Sakarya, Turkiye
[3] Sakarya Univ, Dept Radiol, Fac Med, Sakarya, Turkiye
[4] Sakarya Univ, Dept Pulmonol, Fac Med, Sakarya, Turkiye
关键词
Rheumatoid arthritis; Interstitial lung disease; Carbon monoxide diffusion capacity; Spirometric function tests; INVOLVEMENT; MORTALITY; PROVEN; COHORT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: Rheumatoid Arthritis (RA) stands as the most prevalent form of inflammatory arthritis, affecting approximately 1% of the population. Among individuals diagnosed with RA, a notable proportion, ranging from 10% to 40%, also experience Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD). This coexistence of RA and ILD has been identified as a detrimental factor contributing to increased mortality rates. Furthermore, RA-ILD often exhibits an insidious nature, posing challenges in its timely detection and management. Hence, our objective was to conduct a retrospective analysis of the clinical characteristics observed in patients who underwent evaluation for RA-ILD. PATIENTS AND METHODS: A total of 87 patients who were evaluated for RA- ILD within one year were included in the study. This study was conducted retrospectively using a cross-sectional and descriptive approach to analyze the demographic and clinical data of the included patients. RESULTS: Among the 87 patients, eight were diagnosed with RA-ILD, with four being male and four being female. Of the eight patients, two had non- specific interstitial pneumonia, five had usual interstitial pneumonia, and one had nodules consistent with RA. Subpleural fibrosis increased the likelihood of RA-ILD by 6.9 times. In the group with ILD, the residual volume and total capacity were found to be lower compared to the other group. Among the eight patients diagnosed with RA-ILD, five had used methotrexate before the diagnosis. CONCLUSIONS: In order to mitigate the risk of delayed diagnosis of RA-ILD, which can lead to increased mortality and has a subtle onset, it is recommended that patients with RA who possess certain risk factors undergo regular monitoring. It is advisable for RA patients to undergo annual assessments involving carbon monoxide diffusion capacity and spirometry function tests. In cases, where deemed necessary, more advanced investigations such as high-resolution computed tomography should be conducted.
引用
收藏
页码:8486 / 8493
页数:8
相关论文
共 50 条
  • [41] Clinical features and predictive factors in psoriatic arthritis-related uveitis
    Queiro, R
    Torre, JC
    Belzunegui, J
    González, C
    de Dios, JR
    Unanue, F
    Figueroa, M
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2002, 31 (04) : 264 - 270
  • [42] Integrating bioinformatic resources to identify characteristics of rheumatoid arthritis-related usual interstitial pneumonia
    Qiu, Yulu
    Liu, Chang
    Shi, Yumeng
    Hao, Nannan
    Tan, Wenfeng
    Wang, Fang
    BMC GENOMICS, 2023, 24 (01)
  • [43] Patients with limited rheumatoid arthritis-related interstitial lung disease have a better prognosis than those with extensive disease
    Sathi, Navtej
    Urwin, Thomas
    Desmond, Sean
    Dawson, Julie K.
    RHEUMATOLOGY, 2011, 50 (03) : 620 - 620
  • [44] Rheumatoid arthritis-related interstitial lung disease (RA-ILD): a possible association between disease activity and prognosis
    Jorge Rojas-Serrano
    Mayra Mejía
    Pedro A. Rivera-Matias
    Denisse Herrera-Bringas
    Diana I. Pérez-Román
    Renzo Pérez-Dorame
    Heidegger Mateos-Toledo
    Clinical Rheumatology, 2022, 41 : 1741 - 1747
  • [45] EFFECTS OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE: A SINGLE-CENTRE EXPERIENCE FROM TURKEY
    Eroglu, D. Sahin
    Colaklar, A.
    Baysal, S.
    Torgutalp, M.
    Baygul, A.
    Yayla, E.
    Turgay, T. M.
    Kinikli, G.
    Ates, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 532 - 533
  • [46] SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment
    Narvaez, Javier
    del Campo Fontecha, Petra Diaz
    Garcia, Noe Brito
    Bonilla, Gema
    Aburto, Myriam
    Castellvi, Ivan
    Cano-Jimenez, Esteban
    Mena-Vazquez, Natalia
    Asuncion Nieto, M.
    Maria Ortiz, Ana
    Valenzuela, Claudia
    Abad Hernandez, Miguel Angel
    Castrejon, Isabel
    Correyero Plaza, Maria
    Francisco Hernandez, Felix Manuel
    Hernandez Hernandez, Maria Vanesa
    Rodriquez Portal, Jose Antonio
    REUMATOLOGIA CLINICA, 2022, 18 (09): : 501 - 512
  • [47] Nintedanib for the treatment of refractory progressive rheumatoid arthritis-related interstitial lung disease: a real-life case series
    Narvaez, Javier
    Vicens-Zygmunt, Vanesa
    Alegre, Juan-Jose
    Herrera-Lara, Silvia
    Nolla, Joan-Miquel
    Molina-Molina, Maria
    RHEUMATOLOGY, 2020, 59 (12) : 3983 - 3986
  • [48] Clinical Features of the Acute Exacerbation of Rheumatoid Arthritis-Associated Interstitial Lung Disease
    Koyama, K.
    Kawano, H.
    Yamashita, Y.
    Imakura, T.
    Takahashi, N.
    Naito, N.
    Sato, S.
    Nishioka, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [49] Rheumatoid arthritis-related interstitial lung disease (RA-ILD): a possible association between disease activity and prognosis
    Rojas-Serrano, Jorge
    Mejia, Mayra
    Rivera-Matias, Pedro A.
    Herrera-Bringas, Denisse
    Perez-Roman, Diana, I
    Perez-Dorame, Renzo
    Mateos-Toledo, Heidegger
    CLINICAL RHEUMATOLOGY, 2022, 41 (06) : 1741 - 1747
  • [50] Integrating bioinformatic resources to identify characteristics of rheumatoid arthritis-related usual interstitial pneumonia
    Yulu Qiu
    Chang Liu
    Yumeng Shi
    Nannan Hao
    Wenfeng Tan
    Fang Wang
    BMC Genomics, 24